Antibody Drugs Customized by Genotype

June 12, 2009 | Source: Technology Review

PIKAMAB believes that it can make monoclonal antibodies (engineered to hone in on specific biological targets) more effective by grouping patients together based on their genotype and offering a customized antibody developed for that genotype.

The company hopes that this “stratified” approach to drug development and treatment will help drug companies achieve better results.